NovaBay
This person does not yet have a bio.Content by NovaBay
| 5 min read
There is strong demand for
new anti-infectives, but major factors are slowing down their commercialization. There are, however, a variety of promising initiatives, including advances
involving non-antibiotic anti-infectives and host defense proteins.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Overcoming barriers in gene therapy
Advanced gene editing, delivery, and analytical tools are driving better gene therapies.
A multiomic approach to profiling brain tumors
Probing the molecular drivers of brain metastasis reveals novel therapeutic targets.
Enhancing immune cell profiling with digital technologies
Software innovations help researchers decode immune complexity in cancer.
